DMX200

Search documents
Amicus Therapeutics (FOLD) FY Conference Transcript
2025-06-10 19:00
Amicus Therapeutics (FOLD) FY Conference June 10, 2025 02:00 PM ET Speaker0 Bradley Campbell, the President and CEO of Anicus Therapeutics. Thank you so much for being here. Speaker1 Thank you for having us. Thanks to Goldman for hosting the conference. Nice to see everybody here today. Speaker0 Thank you. And to start off with a big picture question, can you give us a snapshot of your business today and your strategy with regard to commercial execution in the half of the year? Speaker1 Sure. Yes. At Amicus ...
Amicus Therapeutics(FOLD) - 2025 Q1 - Earnings Call Transcript
2025-05-01 12:30
Amicus Therapeutics (FOLD) Q1 2025 Earnings Call May 01, 2025 08:30 AM ET Speaker0 Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics first quarter twenty twenty five financial results conference call and webcast. At this time, participants are in a listen only mode. Later, we will conduct a question and answer session, and instructions will follow at that time. As a reminder, this conference call, it is being recorded. I would now like to turn the conference call over to your host, ...
Amicus Therapeutics(FOLD) - 2025 Q1 - Earnings Call Transcript
2025-05-01 12:30
Amicus Therapeutics (FOLD) Q1 2025 Earnings Call May 01, 2025 08:30 AM ET Company Participants Andrew Faughnan - Vice President, Investor RelationsBradley Campbell - CEO, President & DirectorSébastien Martel - Chief Business OfficerJeffrey Castelli - Chief Development OfficerSimon Harford - CFOJoshua Fleishman - Biotech Equity Research Associate Conference Call Participants Anupam Rama - AnalystNone - AnalystDennis Ding - Vice President - Equity Research AnalystRick Miller - AnalystGil Blum - Senior Analyst ...